Trials / Completed
CompletedNCT02681952
A Multicenter, Randomized, Open-labeled, Cross-over, Active-controlled, Phase IV Clinical Trial to Evaluate the Preference of Formulation and the Efficacy and Safety of Renamezin and Kremezin in Pre-dialysis Patients With Chronic Renal Failure
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 153 (actual)
- Sponsor
- Daewon Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years – 74 Years
- Healthy volunteers
- Not accepted
Summary
A Multicenter, Randomized, Open-labeled, Cross-over, Active-controlled, Phase IV Clinical Trial to Evaluate the Preference of Formulation and the Efficacy and Safety of Renamezin and Kremezin in Pre-dialysis Patients With Chronic Renal Failure
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Renamezin capsule | |
| DRUG | Kremezin granule |
Timeline
- Start date
- 2015-12-01
- Primary completion
- 2016-12-01
- Completion
- 2016-12-01
- First posted
- 2016-02-15
- Last updated
- 2017-07-06
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02681952. Inclusion in this directory is not an endorsement.